Kwality Pharma Peer Comparison

BSE: 539997

₹3,533.30

₹-32.20 (-0.90%)

As on 13-Oct-2026IST

Market cap

₹3,663 Cr

Revenue (TTM)

₹554 Cr

P/E Ratio

45.2

P/B Ratio

10.3

Div. Yield

0 %

Edit

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	3,663	19,042	17,941	18,554	15,956
Revenue (₹ Cr)	554	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	81.04	273.51	678.07	735.15	666.92
Net Margin (%)	14.55	16.19	28.10	26.88	20.60
RoE (%)	26.26	11.15	19.73	19.16	18.75
Price to Earnings	45.20	64.05	26.96	25.24	24.78
Price-To-Book	10.28	7.09	4.88	4.21	3.96

Income Statement (₹ Cr)

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	553.96	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	557.06	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	418.87	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	135.08	478.55	796.58	941.63	1,139.61
Depreciation	20.04	126.01	78.10	57.58	281.06
EBIT	115.04	352.55	718.48	884.05	858.55
Interest	10.87	52.11	0.88	7.69	190.64
Other Income	3.11	7.37	125.96	165.62	7.45
Exceptional Items	-0.83	12.16	0.00	-49.16	-17.24
Profit before Tax	106.45	319.96	843.56	992.82	658.12
Provision for Tax	25.40	46.45	165.49	257.67	-8.80
Profit after Tax	81.04	273.51	678.07	735.15	666.92

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	331.60	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	0.00	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	36.77	266.35	28.74	91.50	1,392.75
Current Liabilities	225.52	848.06	385.94	627.48	2,077.10
Total Liabilities	592.21	3,705.61	4,037.51	4,921.88	7,246.72

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	175.08	2,525.44	1,291.22	770.28	5,617.77
Current Assets	405.68	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	592.21	3,705.61	4,037.51	4,921.88	7,246.72
Total Debt*	130.46	657.97	0.57	2.50	2,309.68
Net Current Assets	180.16	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	36.98	160.01	17.53	370.49	51.57

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	16.59	342.18	523.24	967.57	537.99
Cash Flow from Investing Activities	-34.91	-325.92	-582.30	-561.67	-369.46
Cash from Financing Activities	7.04	13.62	-46.46	-798.31	-313.53
Net Cash Inflow / Outflow	-11.28	29.88	-105.52	-392.41	-145.00

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	24.01	11.43	24.97	23.39	14.47
ROE (%)	26.26	11.15	19.73	19.16	18.75
ROA (%)	15.59	7.80	18.69	14.95	9.26
EBIT Margin (%)	20.77	20.95	31.41	34.40	26.58
Net Margin (%)	14.55	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	37.94	27.91	15.01	10.69	9.59
EBIT Growth (%)	68.71	58.32	18.45	24.14	16.84
Net Profit Growth (%)	86.84	149.56	19.61	-9.09	62.68
EPS Growth (%)	88.04	-3.57	17.73	14.40	67.41
Book Value Growth (%)	25.66	9.67	26.75	-0.34	36.71

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	44.87	67.94	26.96	24.05	24.15
Price / Book Value	10.28	7.09	4.88	4.21	3.96
Dividend Yield (%)	0.00	0.06	0.34	1.85	0.00
EV/EBITDA	28.06	41.07	21.26	16.40	15.97
Market Cap (₹ Cr)	1,355.51	6,819.66	11,439.22	21,592.90	17,980.08

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.09	0.07	0.00	0.00	0.24
Short term debt to equity ratio	0.26	0.16	0.00	0.00	0.12
Current Ratio	1.80	1.31	6.70	6.06	0.74
Quick Ratio	1.45	0.88	5.59	5.31	0.53
Interest Coverage	10.79	7.14	959.59	130.11	4.45

	Kwality Pharma	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	50.55	30.84	36.10	7.07	21.07
Asset Turnover	1.07	0.48	0.63	0.52	0.45
Receivable days	157.57	113.81	121.68	26.06	63.88
Inventory Days	58.67	84.76	63.83	65.95	43.27
Payable days	160.16	101.94	108.28	81.01	151.85
Cash Conversion Cycle	56.07	96.62	77.23	11.00	-44.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.